BridgeBio(BBIO) - 2025 Q2 - Earnings Call Transcript

BridgeBio Pharma (BBIO) Q2 2025 Earnings Call August 05, 2025 04:30 PM ET Company ParticipantsChinmay Shukla - VP Strategic Finance & IRNeil Kumar - CEO & DirectorMatthew Outten - Chief Commercial OfficerThomas Trimarchi - President & CFOJustin To - CEO - Skeletal Dysplasias (QED Therapeutics)None - ExecutiveCory Kasimov - Senior Managing DirectorAnanth Sridhar - COOMani Foroohar - Senior Managing Director - Genetic MedicinesChristine Siu - CEO - ML Bio SolutionsGreg Harrison - Director - BiotechnologyAndre ...